Article
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2011
Wright Jonathan L, Kwon Erika M, Ostrander Elaine A, Montgomery R Bruce, Lin Daniel W, Vessella Robert, Stanford Janet L, Mostaghel Elahe A
Abstract excerpt
BACKGROUND: Metastases from men with castration-resistant prostate cancer (CRPC) harbor increased tumoral androgens versus untreated prostate cancers. This may reflect steroid uptake by OATP (organic anion transporting polypeptide)/SLCO transporters. We evaluated SLCO gene expression in CRPC metastases and determined whether prostate cancer outcomes are associated with single nucleotide polymorphisms (SNP) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
